Benjamin Derman to High-Throughput Nucleotide Sequencing
This is a "connection" page, showing publications Benjamin Derman has written about High-Throughput Nucleotide Sequencing.
Connection Strength
0.315
-
Measurable Residual Disease and Decision-Making in Multiple Myeloma. Hematol Oncol Clin North Am. 2024 04; 38(2):477-495.
Score: 0.177
-
Clinician attitudes and practices toward measurable residual disease in multiple myeloma. Br J Haematol. 2020 08; 190(3):470-472.
Score: 0.138